Sigma Healthcare Ltd (ASX: SIG) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Sigma Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$33.01 billion
P/E Ratio
679.55
Dividend Yield
0.35%
Shares Outstanding
11.54 billion
Earnings per share
-0.009
Dividend per share
0.01
Year To Date Return
9.54%
Earnings Yield
0.15%
Franking
-
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Should you invest $1,000 in Sigma Healthcare right now?
Before you buy Sigma Healthcare shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 6 March 2025
Sigma Healthcare Ltd (ASX: SIG)
Latest News
Share Gainers
Here are the top 10 ASX 200 shares today
Earnings Results
Sigma shares climb after reporting massive 878% profit jump for FY25
Share Market News
Which ASX 200 sectors were the most resilient during the market sell-off?
Opinions
2 high-quality ASX stocks to buy as the tariff sell-off worsens
Healthcare Shares
This little-known healthcare company is now the 17th-largest business in the ASX 200
Share Gainers
Here are the top 10 ASX 200 shares today
52-Week Highs
These ASX 200 shares just hit new 52-week highs
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Here are the top 10 ASX 200 shares today
Healthcare Shares
Sigma share price up 9% on first day of trading post-merger with Chemist Warehouse
Share Market News
ASX 200 strikes new record high
Healthcare Shares
Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 01 Oct 2024 | $0.0050 | 0.00% | Interim | 17 Oct 2024 |
| 28 Mar 2024 | $0.0050 | 50.00% | Final | 17 Apr 2024 |
| 25 Sep 2023 | $0.0050 | 100.00% | Interim | 11 Oct 2023 |
| 30 Mar 2023 | $0.0050 | 100.00% | Final | 18 Apr 2023 |
| 29 Sep 2022 | $0.0050 | 100.00% | Interim | 12 Oct 2022 |
| 04 Apr 2022 | $0.0100 | 100.00% | Final | 22 Apr 2022 |
| 24 Sep 2021 | $0.0100 | 100.00% | Interim | 08 Oct 2021 |
| 06 Apr 2021 | $0.0100 | 100.00% | Final | 21 Apr 2021 |
| 19 Sep 2019 | $0.0100 | 100.00% | Interim | 04 Oct 2019 |
| 03 Apr 2019 | $0.0200 | 100.00% | Final | 29 Apr 2019 |
| 12 Oct 2018 | $0.0150 | 100.00% | Interim | 29 Oct 2018 |
| 05 Apr 2018 | $0.0250 | 100.00% | Final | 20 Apr 2018 |
| 19 Sep 2017 | $0.0250 | 100.00% | Interim | 05 Oct 2017 |
| 06 Apr 2017 | $0.0300 | 100.00% | Final | 21 Apr 2017 |
| 20 Sep 2016 | $0.0250 | 100.00% | Interim | 03 Oct 2016 |
| 06 Apr 2016 | $0.0300 | 100.00% | Final | 21 Apr 2016 |
| 03 Apr 2014 | $0.0200 | 100.00% | Final | 30 Apr 2014 |
| 21 Sep 2012 | $0.0200 | 100.00% | Interim | 26 Oct 2012 |
| 05 Apr 2011 | $0.1500 | 100.00% | Special Cash | 11 May 2011 |
| 16 Oct 2009 | $0.0300 | 100.00% | Interim | 13 Nov 2009 |
| 31 Mar 2009 | $0.0400 | 100.00% | Final | 07 May 2009 |
| 30 Sep 2008 | $0.0300 | 100.00% | Interim | 29 Oct 2008 |
| 29 Aug 2005 | $0.0200 | 100.00% | Interim | 15 Sep 2005 |
| 02 Mar 2004 | $0.2000 | 100.00% | Final | 23 Mar 2004 |
SIG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Sigma Healthcare Ltd
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label. The firm operates through the Amcal, Guardian, PharmaSave, Chemist King, and Discount Drug Stores retail brands. It also involves in the provision of services to retail pharmacists in Australia. The company was founded on July 2, 1999 and is headquartered in Rowville, Australia.
SIG Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 25 Mar 2025 | $2.86 | $0.06 | 2.14% | 44,103,714 | $2.80 | $2.88 | $2.76 |
| 24 Mar 2025 | $2.80 | $-0.07 | -2.44% | 37,806,444 | $2.85 | $2.85 | $2.73 |
| 21 Mar 2025 | $2.87 | $-0.04 | -1.37% | 461,856,090 | $2.91 | $2.95 | $2.81 |
| 20 Mar 2025 | $2.91 | $0.00 | 0.00% | 25,110,331 | $2.95 | $2.95 | $2.84 |
| 19 Mar 2025 | $2.91 | $-0.04 | -1.36% | 24,521,563 | $2.94 | $2.96 | $2.90 |
| 18 Mar 2025 | $2.95 | $-0.01 | -0.34% | 27,223,930 | $2.98 | $3.00 | $2.94 |
| 17 Mar 2025 | $2.96 | $0.08 | 2.78% | 22,492,444 | $2.90 | $3.00 | $2.89 |
| 14 Mar 2025 | $2.88 | $0.08 | 2.86% | 13,458,702 | $2.84 | $2.91 | $2.81 |
| 13 Mar 2025 | $2.80 | $0.04 | 1.45% | 11,242,628 | $2.76 | $2.82 | $2.75 |
| 12 Mar 2025 | $2.76 | $-0.04 | -1.43% | 28,287,530 | $2.77 | $2.78 | $2.72 |
| 11 Mar 2025 | $2.80 | $-0.09 | -3.11% | 23,539,597 | $2.87 | $2.88 | $2.73 |
| 10 Mar 2025 | $2.89 | $0.00 | 0.00% | 14,540,522 | $2.90 | $2.93 | $2.86 |
| 07 Mar 2025 | $2.89 | $-0.03 | -1.03% | 13,099,988 | $2.88 | $2.91 | $2.86 |
| 06 Mar 2025 | $2.92 | $0.03 | 1.04% | 18,172,395 | $2.89 | $2.95 | $2.85 |
| 05 Mar 2025 | $2.89 | $-0.04 | -1.37% | 11,046,075 | $2.89 | $2.93 | $2.88 |
| 04 Mar 2025 | $2.93 | $-0.01 | -0.34% | 20,819,458 | $2.92 | $2.96 | $2.87 |
| 03 Mar 2025 | $2.94 | $0.00 | 0.00% | 10,091,323 | $2.96 | $2.98 | $2.91 |
| 28 Feb 2025 | $2.94 | $-0.05 | -1.67% | 25,732,336 | $3.00 | $3.06 | $2.93 |
| 27 Feb 2025 | $2.99 | $0.01 | 0.34% | 20,780,843 | $3.00 | $3.01 | $2.95 |
| 26 Feb 2025 | $2.98 | $-0.02 | -0.67% | 12,425,932 | $3.00 | $3.01 | $2.94 |
| 25 Feb 2025 | $3.00 | $0.02 | 0.67% | 16,000,513 | $2.99 | $3.01 | $2.95 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 14 Feb 2025 | Vikesh Ramsunder | Buy | 1,965,878 | $6,133,539 |
Conversion of securities.
|
| 14 Feb 2025 | Vikesh Ramsunder | Exercise | 1,965,878 | $6,133,539 |
Conversion of securities. 1,010,723 - Rights
|
| 14 Feb 2025 | Damien Gance | Sell | 40,000,000 | $120,000,000 |
Off-market trade.
|
| 13 Feb 2025 | Vikesh Ramsunder | Sell | 11,662,028 | $34,053,121 |
On-market trade. Average Price
|
| 12 Feb 2025 | Vikesh Ramsunder | Buy | 1,167,106 | $3,221,212 |
Conversion of securities.
|
| 12 Feb 2025 | Vikesh Ramsunder | Exercise | 1,167,106 | $3,221,212 |
Conversion of securities. 4,921,778 - Rights
|
| 12 Feb 2025 | Vikesh Ramsunder | Expiry | 1,945,177 | $5,368,688 |
As advised by the company. 2,976,601 - Rights
lapse of remaining 1,945,177 EEG Rights |
| 10 Jul 2024 | Annette Carey | Buy | 3,662 | $4,681 |
Directors' share plan.
|
| 10 Jul 2024 | Christopher Roberts | Buy | 3,661 | $4,680 |
Directors' share plan.
|
| 10 Jul 2024 | Neville Mitchell | Buy | 4,340 | $5,548 |
Directors' share plan.
|
| 10 Jul 2024 | Kathryn (Kate) Spargo | Buy | 4,747 | $6,067 |
Directors' share plan.
|
| 10 Jul 2024 | Michael Sammells | Buy | 7,866 | $10,054 |
Directors' share plan.
|
| 09 Jul 2024 | Vikesh Ramsunder | Issued | 1,253,717 | $1,611,026 |
Issue of securities. 6,088,884 - Rights
|
| 08 Apr 2024 | Michael Sammells | Buy | 7,855 | $9,582 |
Directors' share plan.
|
| 08 Apr 2024 | Kathryn (Kate) Spargo | Buy | 4,740 | $5,782 |
Directors' share plan.
|
| 08 Apr 2024 | Neville Mitchell | Buy | 4,334 | $5,286 |
Directors' share plan.
|
| 08 Apr 2024 | Annette Carey | Buy | 3,656 | $4,459 |
Directors' share plan.
|
| 08 Apr 2024 | Christopher Roberts | Buy | 3,657 | $4,461 |
Directors' share plan.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Christopher Graham Roberts | Non-Executive Director | Oct 2023 |
Dr Roberts has more than 40 years' experience in the medical device industry, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a Director until November 2017. He Held Directorship in Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
|
| Mr Neville Mitchell | Non-Executive Director | Feb 2023 |
Mr Mitchell has financial experience coupled with experience as an active Non-Executive Director. Mr Mitchell is a current Director and Chair of the Audit Committee of Sonic Healthcare. Mr Mitchell is also a Non-Executive Director and Chair of the Audit and Risk Committee of Fisher and Paykel Healthcare. Previously, Mr Mitchell has held other Director roles including South Eastern Sydney Local Health District, The Board of Taxation, Sirtex Medical and Osprey Medical Inc. Mr Mitchell is a qualified Chartered Accountant with international healthcare and finance experience. Prior to becoming a Non-Executive Director, Mr Mitchell had a career spanning 27 years with Cochlear Limited, 22 of those years as Chief Financial Officer and Company Secretary.
|
| Mr Michael Sammells | Non-Executive DirectorInterim Chairman | Feb 2020 |
Mr Sammells has 35 years of broad experience in finance, corporate services and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a current Director of GMHBA Limited and is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
|
| Mr Vikesh Ramsunder | Chief Executive OfficerManaging Director | Feb 2022 |
Mr Ramsunder has culmination of a 28 year career with the Clicks Group which included 18 years as part of the executive team. Before becoming Clicks CEO Vikesh held a number of roles within the Group, including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesaler business, United Pharmaceutical Distributors.
|
| Ms Annette May Carey | Non-Executive Director | Apr 2023 |
Ms Carey is a current Director of National Intermodal Corporation, a Non-Executive Director of Flinders Port Holdings Pty Ltd, a Non-Executive Director of Kinetic, and an Advisory Board Member of Orizontas. Prior to that, Ms Carey has been a Director of Linfox Armaguard Pty Ltd and Sai Cheng Logistics Inc and was Chair of Australia Post Global. Ms Carey brings a balance of technical expertise as well as legal, strategic, and commercial intellect from over 20 years' experience in supply chain, logistics and cross border ecommerce. Ms Carey has previously held various senior roles within the Linfox Logistics group progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post. Ms Carey is a member of Chief Executive Women.
|
| Mr Jack Gance | Non-Executive Director | Feb 2025 |
--
|
| Ms Danielle Di Pilla | Non-Executive Director | Feb 2025 |
--
|
| Mr Mario Verrocchi | Non-Executive Director | Feb 2025 |
--
|
| Mr Damien Gance | Non-Executive Director | Feb 2025 |
--
|
| Ms Kara McGowan | General CounselCompany Secretary | Oct 2021 |
-
|
| Kara McGowan | General CounselCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Hmc Capital Partners Holdings Pty Ltd | 311,242,135 | 19.07% |
| Hsbc Custody Nominees (Australia) Limited | 295,751,528 | 18.12% |
| Citicorp Nominees Pty Limited | 248,058,343 | 15.20% |
| J P Morgan Nominees Australia Pty Limited | 164,445,049 | 10.08% |
| National Nominees Limited | 64,967,710 | 3.98% |
| Sigma Employee Share Admin P/L | 37,184,497 | 2.28% |
| Pacific Custodians Pty Limited | 32,103,793 | 1.97% |
| Ubs Nominees Pty Ltd | 27,854,014 | 1.71% |
| Bnp Paribas Nominees Pty Ltd | 12,983,279 | 0.80% |
| Hsbc Custody Nominees (Australia) Limited II | 11,673,531 | 0.72% |
| Bnp Paribas Noms Pty Ltd | 11,172,115 | 0.68% |
| Invia Custodian Pty Limited | 7,596,481 | 0.47% |
| Hsbc Custody Nominees (Australia) Limited A/C 2 | 7,365,783 | 0.45% |
| Warbont Nominees Pty Ltd | 5,805,877 | 0.36% |
| Lygon Finance Pty Ltd | 4,906,459 | 0.30% |
| Citicorp Nominees Pty Limited II | 4,794,059 | 0.29% |
| Merrill Lynch (Australia) Nominees Pty Limited | 4,281,681 | 0.26% |
| Bnpp Noms Pty Ltd Hub24 Custodial Serv Ltd | 4,049,515 | 0.25% |
| Bnp Paribas Nominees Pty Ltd Barclays | 3,406,856 | 0.21% |
| Netwealth Investments Limited | 3,315,488 | 0.20% |